
|Videos|November 5, 2021
The Role of Potassium-Binding Agents in Treating Hyperkalemia
Dr. Cary Boyd-Shiwarski explained the effectiveness of potassium-binding agents in treating hyperkalemia in resistant hypertension and CKD.
Advertisement
Pharmacy Times spoke to Dr. Cary Boyd-Shiwarski about her session at the ASN 2021 conference titled "Mechanisms of Potassium Handling in CKD."
Boyd explained the effectiveness of potassium-binding agents in treating hyperkalemia in resistant hypertension and CKD.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Pharmacists as the Glue in Cardio-Kidney-Metabolic Care
2
Building a CDTM Program Means Starting Small
3
Extended-Interval Tarlatamab Dosing Offers Pharmacists More Flexible Administration Windows in SCLC
4
Pharmacists Can Close the LDL Control Gap in Lipid Care
5




































































































